tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:CHM Stock Latest News

Chimeric Therapeutics Posts Strong CDH17 CAR‑T Data and Gains FDA Orphan Status for Gastric Cancer
Company AnnouncementsChimeric Therapeutics Posts Strong CDH17 CAR‑T Data and Gains FDA Orphan Status for Gastric Cancer
3d ago
CHM
Chimeric Therapeutics Issues 309.9 Million New Shares Under Regulatory Notice
PremiumCompany Announcements
Chimeric Therapeutics Issues 309.9 Million New Shares Under Regulatory Notice
24d ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 309.9 Million New Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for 309.9 Million New Shares
24d ago
CHM
Chimeric Therapeutics Announces Change in Substantial Holding After Share Placement
PremiumCompany Announcements
Chimeric Therapeutics Announces Change in Substantial Holding After Share Placement
26d ago
CHM
Chimeric Therapeutics Issues 466.7 Million New Shares Under Section 708A
PremiumCompany Announcements
Chimeric Therapeutics Issues 466.7 Million New Shares Under Section 708A
1M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 466.7 Million New Shares
PremiumCompany AnnouncementsChimeric Therapeutics Seeks ASX Quotation for 466.7 Million New Shares
1M ago
CHM
Chimeric Therapeutics Plans Major Capital Raise via Shares, Notes and Options
Premium
Company Announcements
Chimeric Therapeutics Plans Major Capital Raise via Shares, Notes and Options
1M ago
CHM
Chimeric Therapeutics Issues 16.7 Million Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Chimeric Therapeutics Issues 16.7 Million Unquoted Options Under Employee Incentive Scheme
1M ago
CHM
Chimeric Therapeutics Grants 16.7 Million Unlisted Options to Director Miles Prince
PremiumCompany Announcements
Chimeric Therapeutics Grants 16.7 Million Unlisted Options to Director Miles Prince
1M ago
CHM
Chimeric Therapeutics Shares Halted Ahead of Material Capital Raising Announcement
PremiumCompany Announcements
Chimeric Therapeutics Shares Halted Ahead of Material Capital Raising Announcement
1M ago
CHM
Chimeric Therapeutics’ CHM 1107 Receives FDA Orphan Drug Designation for Gastric Cancer
PremiumCompany Announcements
Chimeric Therapeutics’ CHM 1107 Receives FDA Orphan Drug Designation for Gastric Cancer
2M ago
CHM
Chimeric Therapeutics Announces Board Changes and Promising Trial Results
PremiumCompany Announcements
Chimeric Therapeutics Announces Board Changes and Promising Trial Results
2M ago
CHM
Chimeric Therapeutics Announces Director Resignation
PremiumCompany AnnouncementsChimeric Therapeutics Announces Director Resignation
2M ago
CHM
Chimeric Therapeutics AGM Results and Leadership Changes
Premium
Company Announcements
Chimeric Therapeutics AGM Results and Leadership Changes
2M ago
CHM
Chimeric Therapeutics Highlights Risks in Clinical Trials and Regulatory Processes
Premium
Company Announcements
Chimeric Therapeutics Highlights Risks in Clinical Trials and Regulatory Processes
2M ago
CHM
Chimeric Therapeutics Secures $4.5M R&D Tax Incentive to Boost Cancer Therapy Development
PremiumCompany Announcements
Chimeric Therapeutics Secures $4.5M R&D Tax Incentive to Boost Cancer Therapy Development
2M ago
CHM
Chimeric Therapeutics Reports Promising Results in CHM CDH17 Clinical Trial
PremiumCompany Announcements
Chimeric Therapeutics Reports Promising Results in CHM CDH17 Clinical Trial
3M ago
CHM
Chimeric Therapeutics Temporarily Halts Phase 1b Trial Due to Supply Chain Issues
PremiumCompany Announcements
Chimeric Therapeutics Temporarily Halts Phase 1b Trial Due to Supply Chain Issues
3M ago
CHM
Chimeric Therapeutics Reports Promising ADVENT-AML Trial Results
PremiumCompany Announcements
Chimeric Therapeutics Reports Promising ADVENT-AML Trial Results
3M ago
CHM
Chimeric Therapeutics Advances Clinical Trials and Expands Leadership
PremiumCompany AnnouncementsChimeric Therapeutics Advances Clinical Trials and Expands Leadership
3M ago
CHM
Chimeric Therapeutics Advances in CAR T-Cell Therapy for GI Cancers
Premium
Company Announcements
Chimeric Therapeutics Advances in CAR T-Cell Therapy for GI Cancers
3M ago
CHM
Chimeric Therapeutics Issues New Equity Securities to Support Growth
Premium
Company Announcements
Chimeric Therapeutics Issues New Equity Securities to Support Growth
4M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >